Related references
Note: Only part of the references are listed.Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis
Devaraj Ezhilarasan
JOURNAL OF CELLULAR PHYSIOLOGY (2022)
Advantages and challenges in nanomedicines for chronic liver diseases: A hepatologist's perspectives
Devaraj Ezhilarasan
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
Arshi Khanam et al.
CELLS (2021)
Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis
Santosh Kumar et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Nuclear receptors in liver fibrosis
Philipp Koenigshofer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)
Imatinib inhibits the malignancy of hepatocellular carcinoma by suppressing autophagy
Meng-Chao Xiao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Diagnosis and Treatment of Alcohol-Associated Liver Disease A Review
Ashwani K. Singal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy
Qian-Qian Fan et al.
BIOMATERIALS (2020)
Critical role of estrogen in the progression of chronic liver diseases
Devaraj Ezhilarasan
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2020)
Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy
Xuanyan Cai et al.
PHARMACOLOGICAL RESEARCH (2020)
Retinoids in health and disease: A role for hepatic stellate cells in affecting retinoid levels
Maya W. Haaker et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2020)
Co-delivery of miR-29b and germacrone based on cyclic RGD-modified nanoparticles for liver fibrosis therapy
De Ji et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
Peroxisome proliferator-activated receptor γ inhibits hepatic stellate cell activation regulated by miR-942 in chronic hepatitis B liver fibrosis
Le Tao et al.
LIFE SCIENCES (2020)
MicroRNA interplay between hepatic stellate cell quiescence and activation
Devaraj Ezhilarasan
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Endothelin-1 in portal hypertension: The intricate role of hepatic stellate cells
Devaraj Ezhilarasan
EXPERIMENTAL BIOLOGY AND MEDICINE (2020)
Zein/Phospholipid Composite Nanoparticles for Successful Delivery of Gallic Acid into aHSCs: Influence of Size, Surface Charge, and Vitamin A Coupling
Shaimaa Ali Ali Radwan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Impact of Reverse Micelle Loaded Lipid Nanocapsules on the Delivery of Gallic Acid into Activated Hepatic Stellate Cells: A Promising Therapeutic Approach for Hepatic Fibrosis
Shaimaa Ali Ali Radwan et al.
PHARMACEUTICAL RESEARCH (2020)
Burden of liver diseases in the world
Sumeet K. Asrani et al.
JOURNAL OF HEPATOLOGY (2019)
Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis
Zhijin Chen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Gold nanoclusters as a near-infrared fluorometric nanothermometer for living cells
Hailiang Zhang et al.
MICROCHIMICA ACTA (2019)
An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis
Yanping Li et al.
JOURNAL OF CONTROLLED RELEASE (2019)
TGF-β induces liver fibrosis via miRNA-181a-mediated down regulation of augmenter of liver regeneration in hepatic stellate cells
Parul Gupta et al.
PLOS ONE (2019)
siRNA- and miRNA-based therapeutics for liver fibrosis
Zhen Zhao et al.
TRANSLATIONAL RESEARCH (2019)
Theranostic Quercetin Nanoparticle for Treatment of Hepatic Fibrosis
Qiang Zhang et al.
BIOCONJUGATE CHEMISTRY (2019)
Synergistic MicroRNA Therapy in Liver Fibrotic Rat Using MRI-Visible Nanocarrier Targeting Hepatic Stellate Cells
Jun Wu et al.
ADVANCED SCIENCE (2019)
被撤回的出版物: Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis (Retracted article. See MAR, 2023)
Shao-ce Zhi et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Nanoparticle mediated silencing of tenascin C in hepatic stellate cells: effect on inflammatory gene expression and cell migration
Juan L. Vivero-Escoto et al.
JOURNAL OF MATERIALS CHEMISTRY B (2019)
PGE(2) induces apoptosis of hepatic stellate cells and attenuates liver fibrosis in mice by downregulating miR-23a-5p and miR-28a-5p
R. Brea et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Oral vitamin-A-coupled valsartan nanomedicine: High hepatic stellate cell receptors accessibility and prolonged enterohepatic residence
Nesrine S. El-Mezayen et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Liver fibrosis: Direct antifibrotic agents and targeted therapies
Detlef Schuppan et al.
MATRIX BIOLOGY (2018)
Development of a peptide-modified siRNA nanocomplex for hepatic stellate cells
Zhen Zhao et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Oxidative stress is bane in chronic liver diseases: Clinical and experimental perspective
Devaraj Ezhilarasan
ARAB JOURNAL OF GASTROENTEROLOGY (2018)
Inorganic Nanomaterials as Highly Efficient Inhibitors of Cellular Hepatic Fibrosis
Fei Peng et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Silibinin induces hepatic stellate cell cycle arrest via enhancing p53/p27 and inhibiting Akt downstream signaling protein expression
Devaraj Ezhilarasan et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2017)
Nanoparticles for the treatment of liver fibrosis
Suchithra Poilil Surendran et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis
Nesrine S. El-Mezayen et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Tenascin-C promotes migration of hepatic stellate cells and production of type I collagen
Jian-Cang Ma et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2016)
Suppressive effect of microRNA-29b on hepatic stellate cell activation and its crosstalk with TGF-β1/Smad3
Chunli Liang et al.
CELL BIOCHEMISTRY AND FUNCTION (2016)
Intracellular trafficking and exocytosis of a multi-component siRNA nanocomplex
Ravi S. Shukla et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical Trials
Kai Qu et al.
FRONTIERS IN PHARMACOLOGY (2016)
Extracellular Matrix Molecular Remodeling in Human Liver Fibrosis Evolution
Andrea Baiocchini et al.
PLOS ONE (2016)
IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner
Hitoshi Nishizawa et al.
SCIENTIFIC REPORTS (2016)
Silibinin Inhibits Proliferation and Migration of Human Hepatic Stellate LX-2 Cells
Devaraj Ezhilarasan et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2016)
Corona-Directed Nucleic Acid Delivery into Hepatic Stellate Cells for Liver Fibrosis Therapy
Zhengping Zhang et al.
ACS NANO (2015)
Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications
Randy Chi Fai Cheung et al.
MARINE DRUGS (2015)
The Use of Nanoparticles to Deliver Nitric Oxide to Hepatic Stellate Cells for Treating Liver Fibrosis and Portal Hypertension
Hien T. T. Duong et al.
SMALL (2015)
microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway
Jia Wang et al.
ONCOTARGET (2015)
Nanomedicines of Hedgehog Inhibitor and PPAR-γ Agonist for Treating Liver Fibrosis
Virender Kumar et al.
PHARMACEUTICAL RESEARCH (2014)
Inhibition of hepatic fibrosis with artificial microRNA using ultrasound and cationic liposome-bearing microbubbles
D. Yang et al.
GENE THERAPY (2013)
miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression
Jiang Li et al.
JOURNAL OF HEPATOLOGY (2013)
Nanoscale hepatoprotective herbal decoction attenuates hepatic stellate cell activity and chloroform-induced liver damage in mice
Sherry Huang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2011)
PCBP2 siRNA Reverses the Alcohol-induced Pro-fibrogenic Effects in Hepatic Stellate Cells
Ravi S. Shukla et al.
PHARMACEUTICAL RESEARCH (2011)
Fabrication and characterization of an inorganic gold and silica nanoparticle mediated drug delivery system for nitric oxide
Amitava Das et al.
NANOTECHNOLOGY (2010)
Expression of large tenascin-C splice variants by hepatic stellate cells/myofibroblasts in chronic hepatitis C
Amro El-Karef et al.
JOURNAL OF HEPATOLOGY (2007)
Engagement of αvβ3 integrin regulates proliferation and apoptosis of hepatic stellate cells
XY Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Dominant-negative soluble PDGF-β receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis
E Borkham-Kamphorst et al.
LABORATORY INVESTIGATION (2004)
Share Paper
